3.05
12.10%
-0.42
시간 외 거래:
3.03
-0.02
-0.66%
Zentalis Pharmaceuticals Inc (ZNTL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
40.56
|
- | - | - | - |
Operating Expenses
|
3.82%
65.33
|
67.92 | 62.72 | 103.92 | 64.95 |
Benefits Costs and Expenses |
30.38
|
- | - | - | - |
Costs And Expenses |
30.38
|
- | - | - | - |
Operating Income/Loss |
63.54%
-24.77
|
-67.92 | -62.72 | -103.92 | -64.95 |
Income/Loss Before Equity Method Investments |
116.67%
10.18
|
-61.07 | -55.51 | -99.47 | -60.84 |
Income/Loss From Equity Method Investments |
-
|
- | - | -13.70 | -2.31 |
Income/Loss From Continuing Operations Before Tax |
113.21%
10.18
|
-77.09 | -55.51 | -99.47 | -60.84 |
Income Tax Expense/Benefit |
205.93%
0.143
|
-0.135 | 0.031 | -0.605 | 0.108 |
Income/Loss From Continuing Operations After Tax |
113.05%
10.04
|
-76.95 | -55.54 | -98.86 | -60.95 |
Net Income/Loss
|
116.48%
10.04
|
-60.94 | -55.54 | -112.56 | -63.26 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
27.27%
-0.028
|
-0.022 | -0.012 | -0.037 | -0.043 |
Basic Average Shares |
3,821%
70.90
|
1.808 | 70.61 | 60.79 | 59.28 |
Diluted Average Shares |
3,838%
71.19
|
1.808 | 70.61 | 60.79 | 59.28 |
Basic Earnings Per Share |
116.87%
0.14
|
-0.83 | -0.79 | -1.85 | -1.07 |
Diluted Earnings Per Share |
116.87%
0.14
|
-0.83 | -0.79 | -1.85 | -1.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):